Biohaven
BHVN • NYSE
Biohaven is a biotechnology company in the healthcare sector trading on NYSE, led by CEO Vladimir Coric, with a market cap of $1.3B.
CEOVladimir Coric
Next Earnings
Upcoming earnings announcement for Biohaven
Date
Monday, May 11, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.78
Revenue Estimate
$8.3M
Earnings History
Past 12 earnings reports for Biohaven
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 2, 2026 | Q4 2025 | -$1.21Est: -$1.06 | -14.2% | -Est: $1.5M | -100.0% |  10-K |
| Nov 10, 2025 | Q3 2025 | -$1.47Est: -$1.73 | +15.0% | -Est: $1.9M | -100.0% | 10-Q |
| Aug 11, 2025 | Q2 2025 | -$1.63Est: -$1.72 | +5.2% | - | — | 10-Q |
| May 12, 2025 | Q1 2025 | -$1.64Est: -$1.49 | -10.1% | -Est: $1.4M | -100.0% | 10-Q |
| Mar 3, 2025 | Q4 2024 | -$1.71Est: -$1.56 | -9.6% | -Est: $100.0M | -100.0% | 10-K |
| Nov 12, 2024 | Q3 2024 | -$1.74Est: -$1.72 | -1.2% | - | — | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$3.50Est: -$1.77 | -97.7% | - | — | 10-Q |
| May 9, 2024 | Q1 2024 | -$1.77Est: -$1.57 | -12.7% | - | — | 10-Q |
| Feb 29, 2024 | Q4 2023 | -$1.61Est: -$1.41 | -14.2% | - | — | 10-K |
| Nov 14, 2023 | Q3 2023 | -$1.44Est: -$1.34 | -7.5% | - | — | — |
| Jul 31, 2023 | Q2 2023 | -$1.25Est: -$1.21 | -3.3% | - | — | 10-Q |
| May 12, 2023 | Q1 2023 | -$0.98Est: -$1.39 | +29.5% | - | — | — |